Synlait Milk (SML) H2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2025 earnings summary
16 Jun, 2026Executive summary
Entered binding agreement to sell North Island assets, including Pōkeno and Auckland facilities, to Abbott for NZD 307 million (US$178 million), with completion targeted for April 2026 and major shareholder support secured.
Strategic reset simplifies operations, focusing on South Island/Canterbury, aiming to restore creditworthiness, stakeholder confidence, and operational stability.
Leadership transition with new CEO Richard Wyeth appointed in May 2025, driving operational stability and culture shift.
Financial highlights
FY25 revenue reached a record $1.83 billion, up 12% year-over-year.
Group EBITDA was $50.7 million, up $54.8 million from FY24; underlying EBITDA $107.2 million, up 137%.
Net loss after tax was $39.8 million, a 78% year-on-year improvement; adjusted net profit after tax was $0.8 million.
Net debt reduced by 55% to $250.7 million, mainly due to equity raise and improved trading.
Operating cash flow surged 451% to $165.5 million; gross profit increased to $105.3 million.
Record milk price for 2024/2025 was $10.16/kg of milk solids, with additional incentives for suppliers.
Outlook and guidance
No financial guidance for FY26 due to the scale of the strategic reset and asset sale; updated strategic plan expected by March 2026.
FY26 focus is on executing the North Island sale, operational stability, and simplification.
Latest events from Synlait Milk
- Net loss of $80.6 million, high debt, and asset sale drive a challenging but hopeful recovery.SML
H1 202616 Jun 2026 - Profitability restored with strong EBITDA, reduced debt, and ongoing refinancing and supply risks.SML
H1 202516 Jun 2026 - Major FY24 loss, balance sheet reset, and recovery hinges on trading and milk supply retention.SML
H2 202416 Jun 2026 - North Island asset sale to Abbott and debt reduction strategy mark a pivotal reset.SML
Investor presentation18 May 2026 - Major debt reduction, operational focus, and sustainability targets set for FY25.SML
Investor presentation18 May 2026 - Asset sale and board changes passed with over 99% approval, targeting debt reduction and growth.SML
AGM 20253 Feb 2026 - Major loss, balance sheet reset, and FY25 growth priorities with strong shareholder backing.SML
AGM 202412 Jan 2026